Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Eli Lilly and Company
Pfizer
Astellas Pharma Inc
Dana-Farber Cancer Institute
Astellas Pharma Inc
Arcus Biosciences, Inc.
Pfizer
Children's Oncology Group
AstraZeneca